Quick Takeaways
- Eric Karas has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $175,259.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Eric Karas
- Location
- San Diego, CA
- Summary
- The estimated net worth of Eric Karas is at least $175,259 dollars as of 05 Jan 2026. Eric Karas is the Chief Commercial Officer of ARS Pharmaceuticals, Inc. and owns shares of ARS Pharmaceuticals, Inc. (SPRY) stock worth about $175.3K.
- Signature
- /s/ Kathleen Scott, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Eric Karas and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: ARS Pharmaceuticals, Inc. ($175,259).
- Past-year value change for that position: -$494,861.
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Source Evidence
Filed on Form 4
See Original Filing
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
Ownership of Eric Karas
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | Chief Commercial Officer | $175,259 | -$494,861 | -74% | 02 Jan 2026 |
Insider Transactions Reported by Eric Karas:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.